Gilead Sciences, Inc. (NASDAQ:GILD)
| CAPS Rating |
|
|---|---|
| Open | $53.59 |
| Previous Close | $53.73 |
| Daily Range | $53.42 - $53.96 |
| 52-Week Range | $34.45 - $56.50 |
| Market Cap | $41.47B |
| P/E Ratio | 12.20 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 7,101,965 |
| Average Daily Volume | 0 |
GILD
VS S&P 500 (SPY)
How do you think GILD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GILD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GILD News and Commentary
- 2 Stocks to Beat a Recession – The Motley Fool
- Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary – NASDAQ
- Generic Challenge for UTHR's Remodulin - Analyst Blog – NASDAQ
- Why Did My Stock Just Die? – The Motley Fool
- Company News for February 6, 2012 - Corporate Summary – NASDAQ
- There’s no Stopping Gilead Sciences – Blogs @ The Motley Fool
- 2 Dow Stocks That Missed the Rally – The Motley Fool
- Curing Diseases Makes For a Bad Business Model – The Motley Fool
- Why the Nasdaq's at an 11-Year High Today – The Motley Fool
- Idenix Pharmaceuticals Shares Dropped: What You Need to Know – The Motley Fool
- Gilead Sciences Shares Surged: What You Need to Know – The Motley Fool
- UPDATE: Idenix Says FDA Partial Hold On Hepatitis C Drug Lifted – SmartMoney
- Gilead Sciences Meets on the Top Line, Misses Where it Counts – The Motley Fool
- Gilead Misses EPS Ests, Sales Up - Analyst Blog – NASDAQ
- Has Amgen Become the Perfect Stock? – The Motley Fool
- Maximum Market: $2.9 Billion, For Now – The Motley Fool
- Which Big Biotech Is the Best Bet? – The Motley Fool
- Has Gilead Sciences Become the Perfect Stock? – The Motley Fool
- Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies – Minyanville
- Could These Huge Health-Care Buyouts Continue? – The Motley Fool
RSS Headlines
Fool UK
